Cargando…
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
Pancreatic cancer (PC) is a growing global burden, remaining one of the most lethal cancers of the gastrointestinal tract. Moreover, PC is resistant to various treatments such as chemotherapy, radiotherapy, and immunotherapy. New therapies are urgently needed to improve the prognosis of PC. Oncolyti...
Autores principales: | Luo, Wenhao, Wang, Yawen, Zhang, Taiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022249/ https://www.ncbi.nlm.nih.gov/pubmed/35443724 http://dx.doi.org/10.1186/s12935-022-02583-1 |
Ejemplares similares
-
Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019) -
Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021) -
Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020) -
Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis
por: Luo, Wenhao, et al.
Publicado: (2022) -
Oncolytic viruses in cancer therapy
por: Vähä-Koskela, Markus J.V., et al.
Publicado: (2007)